Baird analyst Jeff Johnson upgraded DexCom (NASDAQ: DXCM) from Neutral to Outperform with a price target of $104.00 (from $86.00).The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE